FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Jean Maroun

Research Profile

Procedures

Chemicals & Drugs

Activities & Behaviors

Drug Evaluation

Disorders

Concepts & Ideas

Geographic Areas

Canada

Co-author Network

Publications

TOP 3
D J Jonker; K Spithoff; Jean Maroun
Adjuvant systemic chemotherapy for Stage II and III colon cancer after complete resection: an updated practice guideline.
D Jonker; Jean Maroun; K Spithoff
Broad funding for oxaliplatin in Ontario (finally!).
B G Le François; Jean Maroun; H Chaim Birnboim
Expression of thymidylate synthase in human cells is an early G(1) event regulated by CDK4 and p16INK4A but not E2F.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Jean Maroun (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2011: D J Jonker; K Spithoff; Jean Maroun
Adjuvant systemic chemotherapy for Stage II and III colon cancer after complete resection: an updated practice guideline.
Clinical oncology (Royal College of Radiologists (Great Britain)) 2011;23(5):314-22.
2007: D Jonker; Jean Maroun; K Spithoff
Broad funding for oxaliplatin in Ontario (finally!).
Current oncology (Toronto, Ont.) 2007;14(6):224-6.
2007: B G Le François; Jean Maroun; H Chaim Birnboim
Expression of thymidylate synthase in human cells is an early G(1) event regulated by CDK4 and p16INK4A but not E2F.
British journal of cancer 2007;97(9):1242-50.
2007: Jean Maroun; Lowell Anthony; N Blais; R Burkes; S D Dowden; G Dranitsaris; B Samson; A Shah; M P Thirlwell; mark vincent; R Wong
Prevention and management of chemotherapy-induced diarrhea in patients with colorectal cancer: a consensus statement by the Canadian Working Group on Chemotherapy-Induced Diarrhea.
Current oncology (Toronto, Ont.) 2007;14(1):13-20.
2007: Hans-Joachim Schmoll; Thomas Cartwright; Josep Tabernero; Marek P Nowacki; Arie Figer; Jean Maroun; Timothy Price; Robert Lim; Eric Van Cutsem; Young-Suk Park; Joseph McKendrick; Claire Topham; Gemma Soler-Gonzalez; Filipo de Braud; Mark Hill; Florin Sirzén; Daniel G Haller
Phase III trial of capecitabine plus oxaliplatin as adjuvant therapy for stage III colon cancer: a planned safety analysis in 1,864 patients.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(1):102-9.
2006: Glenwood Goss; Lillian L Siu; I Gauthier; Eric X Chen; Amit Oza; Rakesh Goel; Jean Maroun; J Powers; Wendy Walsh; Martha Maclean; D W Drolet; J Rusk; LK Seymour
A phase I, first in man study of OSI-7836 in patients with advanced refractory solid tumors: IND.147, a study of the Investigational New Drug Program of the National Cancer Institute of Canada Clinical Trials Group.
Cancer chemotherapy and pharmacology 2006;58(5):703-10.
2006: D Jonker; Jean Maroun; R Bryan Rumble
Role of oxaliplatin combined with 5-fluorouracil and folinic acid in the first- and second-line treatment of advanced colorectal cancer.
Current oncology (Toronto, Ont.) 2006;13(5):173-84.
2006: Jean Maroun; K Belanger; Lesley Seymour; Sarah Matthews; J Roach; Jeanne Dionne; Denis Soulieres; D Stewart; Rakesh Goel; Danielle Charpentier; Glenwood Goss; Eva Tomiak; JC Yau; J Jimeno; G Chiritescu
Phase I study of Aplidine in a dailyx5 one-hour infusion every 3 weeks in patients with solid tumors refractory to standard therapy. A National Cancer Institute of Canada Clinical Trials Group study: NCIC CTG IND 115.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2006;17(9):1371-8.
2006: Jean Maroun; Walter Kocha; LK Kvols; G Bjarnason; E Chen; C Germond; S Hanna; P Poitras; D Rayson; R Reid; J Rivera; A Roy; A Shah; L Sideris; L Siu; R Wong
Guidelines for the diagnosis and management of carcinoid tumours. Part 1: the gastrointestinal tract. A statement from a Canadian National Carcinoid Expert Group.
Current oncology (Toronto, Ont.) 2006;13(2):67-76.
2006: Jean Maroun; Derek Jonker; Lesley Seymour; Rakesh Goel; mark vincent; W Kocha; C Cripps; Bryn Fisher; D Lister; A Malpage; G Chiritescu
A National Cancer Institute of Canada Clinical Trials Group Study--IND.135: Phase I/II study of irinotecan (camptosar), oxaliplatin and raltitrexed (tomudex) (COT) in patients with advanced colorectal cancer.
European journal of cancer (Oxford, England : 1990) 2006;42(2):193-9.
2006: Seema Bissoon-Haqqani; Terence Moyana; Derek Jonker; Jean Maroun; H Chaim Birnboim
Nuclear expression of thymidylate synthase in colorectal cancer cell lines and clinical samples.
The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society 2006;54(1):19-29.
2005: Chris Twelves; Alfred Wong; Marek P Nowacki; Markus Abt; Howard Burris; Alfredo Carrato; Jim Cassidy; Andrés Cervantes; Jan Fagerberg; Vassilis Georgoulias; Fares Husseini; Duncan I Jodrell; Piotr Koralewski; Hendrik Kröning; Jean Maroun; Norbert Marschner; Joseph McKendrick; Marek Pawlicki; Riccardo Rosso; Johannes Schüller; Jean-François Seitz; Borut Stabuc; Jerzy Tujakowski; Guy Van Hazel; Jerzy Zaluski; Werner Scheithauer
Capecitabine as adjuvant treatment for stage III colon cancer.
The New England journal of medicine 2005;352(26):2696-704.
2005: George Dranitsaris; Jean Maroun; Amil Shah
Severe chemotherapy-induced diarrhea in patients with colorectal cancer: a cost of illness analysis.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2005;13(5):318-24.
2005: George Dranitsaris; Jean Maroun; Amil Shah
Estimating the cost of illness in colorectal cancer patients who were hospitalized for severe chemotherapy-induced diarrhea.
Canadian journal of gastroenterology = Journal canadien de gastroenterologie 2005;19(2):83-7.
2004: Alvaro Figueredo; Manya L Charette; Jean Maroun; Melissa Brouwers; Lisa Zuraw
Adjuvant therapy for stage II colon cancer: a systematic review from the Cancer Care Ontario Program in evidence-based care's gastrointestinal cancer disease site group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(16):3395-407.
2004: Eric Van Cutsem; P M Hoff; P Harper; R M Bukowski; D Cunningham; P Dufour; U Graeven; J Lokich; S Madajewicz; Jean Maroun; J L Marshall; E P Mitchell; G Perez-Manga; Philippe Rougier; W Schmiegel; J Schoelmerich; Alberto Sobrero; R L Schilsky
Oral capecitabine vs intravenous 5-fluorouracil and leucovorin: integrated efficacy data and novel analyses from two large, randomised, phase III trials.
British journal of cancer 2004;90(6):1190-7.
2003: W Scheithauer; Joseph McKendrick; S Begbie; M Borner; W I Burns; H A Burris; Jim Cassidy; Duncan I Jodrell; Piotr Koralewski; E L Levine; Norbert Marschner; Jean Maroun; P Garcia-Alfonso; Jerzy Tujakowski; Guy Van Hazel; A Wong; Jerzy Zaluski; Chris Twelves
Oral capecitabine as an alternative to i.v. 5-fluorouracil-based adjuvant therapy for colon cancer: safety results of a randomized, phase III trial.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2003;14(12):1735-43.
2003: Alvaro Figueredo; R Bryan Rumble; Jean Maroun; Craig C Earle; Bernard Cummings; Robin McLeod; Lisa Zuraw; Caroline Zwaal
Follow-up of patients with curatively resected colorectal cancer: a practice guideline.
BMC cancer 2003;3():26.
2003: Craig C Earle; Olusegun Agboola; Jean Maroun; Lisa Zuraw
The treatment of locally advanced pancreatic cancer: a practice guideline.
Canadian journal of gastroenterology = Journal canadien de gastroenterologie 2003;17(3):161-7.
2003: Jean Maroun; Edward Ng; Jean-Marie Berthelot; Christel Le Petit; Simone Dahrouge; William M Flanagan; Hugh Walker; William K Evans
Lifetime costs of colon and rectal cancer management in Canada.
Chronic diseases in Canada 2003;24(4):91-101.
2003: Jean Maroun; Carl V Asche; Françoise Romeyer; Jayanti Mukherjee; Christine Cripps; Amit Oza; Jamie Skillings; Jacques Letarte
A cost comparison of oral tegafur plus uracil/folinic acid and parenteral fluorouracil for colorectal cancer in Canada.
PharmacoEconomics 2003;21(14):1039-51.
2002: Craig C Earle; Jean Maroun; Lisa Zuraw
Neoadjuvant or adjuvant therapy for resectable gastric cancer? A practice guideline.
Canadian journal of surgery. Journal canadien de chirurgie 2002;45(6):438-46.
2002: M Michael; D Hedley; Amit Oza; R Feld; M Pintilie; R Goel; Jean Maroun; J Jolivet; A Fields; I M Lee; M J Moore
The palliative benefit of irinotecan in 5-fluorouracil-refractory colorectal cancer: its prospective evaluation by a Multicenter Canadian Trial.
Clinical colorectal cancer 2002;2(2):93-101.
2002: Jim Cassidy; Chris Twelves; Eric Van Cutsem; P Hoff; Emilio Bajetta; Michael Boyer; R Bugat; U Burger; A Garin; U Graeven; J McKendric; Jean Maroun; J Marshall; B Osterwalder; G Pérez-Manga; R Rosso; Philippe Rougier; R L Schilsky
First-line oral capecitabine therapy in metastatic colorectal cancer: a favorable safety profile compared with intravenous 5-fluorouracil/leucovorin.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2002;13(4):566-75.
2002: Eric Van Cutsem; D Cunningham; Jean Maroun; A Cervantes; Bengt Glimelius
Raltitrexed: current clinical status and future directions.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2002;13(4):513-22.
2001: Anna Tomiak; mark vincent; Craig C Earle; P G Johnston; Walter Kocha; M Taylor; Jean Maroun; L Eidus; Frances Whiston; Larry Stitt
Thymidylate synthase expression in stage II and III colon cancer: a retrospective review.
American journal of clinical oncology 2001;24(6):597-602.
2001: Paulo M Hoff; R Ansari; G Batist; J Cox; Walter Kocha; M Kuperminc; Jean Maroun; D Walde; C Weaver; E Harrison; Hans-Ulrich Burger; B Osterwalder; A O Wong; R Wong
Comparison of oral capecitabine versus intravenous fluorouracil plus leucovorin as first-line treatment in 605 patients with metastatic colorectal cancer: results of a randomized phase III study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(8):2282-92.
2001: M Borner; W Scheithauer; Chris Twelves; Jean Maroun; H Wilke
Answering patients' needs: oral alternatives to intravenous therapy.
The oncologist 2001;6 Suppl 4():12-6.
2001: Eric Van Cutsem; D Cunningham; P M Hoff; Jean Maroun
Thymidine phosphorylase (TP) activation: convenience through innovation.
The oncologist 2001;6 Suppl 4():1-2.
2000: Derek Jonker; Jean Maroun; W Kocha
Survival benefit of chemotherapy in metastatic colorectal cancer: a meta-analysis of randomized controlled trials.
British journal of cancer 2000;82(11):1789-94.
1999: Arsalan S Haqqani; RT Cowling; Jean Maroun; H Chaim Birnboim
Characterization of a polyclonal antibody to human thymidylate synthase suitable for the study of colorectal cancer specimens.
The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society 1999;47(12):1563-74.
1999: Craig C Earle; Jean Maroun
Adjuvant chemotherapy after curative resection for gastric cancer in non-Asian patients: revisiting a meta-analysis of randomised trials.
European journal of cancer (Oxford, England : 1990) 1999;35(7):1059-64.
1999: D Jonker; R Mehran; Jean Maroun; A Crepeau
Neoadjuvant chemotherapy before surgery for resectable carcinoma of the lower esophagus.
Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus / I.S.D.E 1999;12(2):144-8.
1998: Georg A Bjarnason; C Cripps; Rakesh Goel; S Fine; Amit Oza; J R Skillings; I Kerr; CJ Germond; M J Moore; Jean Maroun; Edmee Franssen; H Dulude
Phase I-II study of 5-fluorouracil, leucovorin, doxorubicin, methotrexate, and long-term oral etoposide (FLAME) in unresectable or metastatic gastric cancer.
American journal of clinical oncology 1998;21(6):537-42.
1998: George Browman; TE Newman; E Ann Mohide; I D Graham; Mark N Levine; Kathleen I Pritchard; William K Evans; Jean Maroun; D I Hodson; M S Carey; Donald H Cowan
Progress of clinical oncology guidelines development using the Practice Guidelines Development Cycle: the role of practitioner feedback.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(3):1226-31.
1998: Jean Maroun; D Stewart; S Verma; E Eisenhauer
Phase I clinical study of didemnin B. A National Cancer Institute of Canada Clinical Trials Group study.
Investigational new drugs 1998;16(1):51-6.
1997: Alvaro Figueredo; C Germond; Jean Maroun; G Browman; C Walker-Dilks; S Wong
Adjuvant therapy for stage II colon cancer after complete resection. Provincial Gastrointestinal Disease Site Group.
Cancer prevention & control : CPC = Prévention & contrôle en cancérologie : PCC 1997;1(5):379-92.
1997: Alvaro Figueredo; S Fine; Jean Maroun; C Walker-Dilks; S Wong
Adjuvant therapy for stage III colon cancer after complete resection. Provincial Gastrointestinal Disease Site Group.
Cancer prevention & control : CPC = Prévention & contrôle en cancérologie : PCC 1997;1(4):304-19.
1997: Jean Maroun; C Cripps; Rakesh Goel; S Dahrouge; D Boisvert
Retrospective comparative analysis of 5FU + low-dose folinic acid vs. 5FU + high-dose folinic acid in the treatment of metastatic colorectal cancer. The Ottawa experience.
American journal of clinical oncology 1997;20(4):387-92.
1995: William K Evans; A Radwi; Eva Tomiak; D M Logan; H Martins; David J Stewart; Glenwood Goss; Jean Maroun; Simone Dahrouge
Oral etoposide and carboplatin. Effective therapy for elderly patients with small cell lung cancer.
American journal of clinical oncology 1995;18(2):149-55.
1995: David J Stewart; L R Morgan; S Verma; Jean Maroun; M Thibault
Pharmacology, relative bioavailability, and toxicity of three different oral cyclophosphamide preparations in a randomized, cross-over study.
Investigational new drugs 1995;13(1):99-107.
1994: William K Evans; David J Stewart; Frances A Shepherd; D Logan; Glenwood Goss; Jean Maroun; R Wierzbicki; E Warner; Jean Latreille; Simone Dahrouge
VP-16, ifosfamide and cisplatin (VIP) for extensive small cell lung cancer.
European journal of cancer (Oxford, England : 1990) 1994;30A(3):299-303.
1992: B Weinerman; A Shah; A Fields; I C Cripps; K Wilson; R McCormick; W Temple; Jean Maroun; W Bogues; J Pater
Systemic infusion versus bolus chemotherapy with 5-fluorouracil in measurable metastatic colorectal cancer.
American journal of clinical oncology 1992;15(6):518-23.
1992: William K Evans; D Stewart; D Logan; Jean Maroun; Glenwood Goss; Frances A Shepherd; Jean Latreille; E Warner; Simone Dahrouge
A phase II study of ifosfamide in combination with etoposide and cisplatin in the treatment of extensive small cell lung cancer.
Seminars in oncology 1992;19(6 Suppl 12):51-6.
1992: David J Stewart; S E Aitken; S Verma; Jean Maroun; L Robillard; M Touchie; I A Prosser; R Earhart
Phase I study of oral menogaril administered daily for 14 consecutive days.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1992;3(5):401-3.
1992: Frances A Shepherd; William K Evans; Paul E Goss; Jean Latreille; D Logan; Jean Maroun; D Stewart; E Warner; K Paul
Ifosfamide, cisplatin, and etoposide (ICE) in the treatment of advanced non-small cell lung cancer.
Seminars in oncology 1992;19(1 Suppl 1):54-8.
1991: J R Skillings; M Levine; H L Rayner; Elizabeth Eisenhauer; C Erlichman; CJ Germond; I Kerr; WS Lofters; Jean Maroun; S Yoshida
Levamisole and 5-fluorouracil therapy for resected colon cancer: a new indication.
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 1991;144(3):297-301.
1991: David J Stewart; D Grewaal; R M Green; S Verma; Jean Maroun; D Redmond; L Robillard; S Gupta
Bioavailability and pharmacology of oral idarubicin.
Cancer chemotherapy and pharmacology 1991;27(4):308-14.
1990: David J Stewart; S Verma; Jean Maroun; L Robillard; D J Perrault; V Young; S Gupta; B Fontaine
Phase I study of idarubicin administered orally on a daily x 3 schedule.
Investigational new drugs 1990;8(3):275-81.
1990: David J Stewart; R Green; N Futter; W Walsh; D McKay; S Verma; Jean Maroun; D Redmond
Phase I and pharmacology study of intravesical mitoxantrone for recurrent superficial bladder tumors.
The Journal of urology 1990;143(4):714-6.
1990: S Verma; David J Stewart; Jean Maroun; Rama Nair
A randomized phase II study of cisplatin alone versus cisplatin plus disulfiram.
American journal of clinical oncology 1990;13(2):119-24.
1990: Frances A Shepherd; Paul E Goss; Jean Latreille; D Stewart; D Logan; William K Evans; Jean Maroun; E Warner
A phase II study of ifosfamide, cisplatin, etoposide in patients with advanced non-small cell lung cancer: a preliminary report.
Seminars in oncology 1990;17(2 Suppl 4):19-23.
1990: David J Stewart; S Verma; Jean Maroun; L Robillard; R H Earhart
Phase I study of oral menogaril administered on a once weekly schedule.
Investigational new drugs 1990;8(1):43-52.
1990: Jean Maroun; David J Stewart
Phase I study of tiazofurin (2-beta-D-ribofuranosylthiazole-4-carboxamide, NSC 286193).
Investigational new drugs 1990;8 Suppl 1():S33-9.
1990: William K Evans; R Wierzbicki; Frances A Shepherd; J Rusthoven; David J Stewart; S E Aitken; Jean Maroun; A Ezzat
5-Fluorouracil with folinic acid is not effective against metastatic adenocarcinoma of the lung.
Cancer investigation 1990;8(3-4):345-9.
1990: B Weinerman; Jean Maroun; D Stewart; C Cripps; J Johnston
Sequential methotrexate, 5-fluorouracil, and leucovorin in metastatic measurable colorectal cancer. Does it work?
Cancer investigation 1990;8(3-4):339-43.
1989: David J Stewart; Jean Maroun; S Verma; D Perrault; R H Earhart
Phase I study of weekly intravenous administration of menogaril to adults with solid tumors.
American journal of clinical oncology 1989;12(6):511-8.
1988: David J Stewart; N Z Mikhael; Rama Nair; S Kacew; V Montpetit; A Nanji; Jean Maroun; K Howard
Platinum concentrations in human autopsy tumor samples.
American journal of clinical oncology 1988;11(2):152-8.
1987: Jean Maroun; Elizabeth Eisenhauer; C Cripps; A Maksymiuk
Phase II study of tiazofurin in colorectal cancer: a National Cancer Institute of Canada Study.
Cancer treatment reports 1987;71(12):1297-8.
1987: David J Stewart; S Verma; Jean Maroun
Phase I study of the combination of disulfiram with cisplatin.
American journal of clinical oncology 1987;10(6):517-9.
1987: Elizabeth A Eisenhauer; Jean Maroun; A L Fields; P L Walde
Phase II study of acivicin as a 72-hr continuous infusion in patients with untreated colorectal cancer. A National Cancer Institute of Canada Clinical Trials Group Study.
Investigational new drugs 1987;5(4):375-8.
1987: David J Stewart; Z Grahovac; H Hugenholtz; N A Russell; M T Richard; B G Benoit; M D Riding; C Danjoux; Jean Maroun
Intraarterial mitomycin-C for recurrent brain metastases.
American journal of clinical oncology 1987;10(5):432-6.
1987: David J Stewart; D J Perrault; Jean Maroun; B M Lefebvre
Combined mitoxantrone plus doxorubicin in the treatment of breast cancer.
American journal of clinical oncology 1987;10(4):335-40.
1987: David J Stewart; C Cripps; Jean Maroun
Phase II study of high-dose mitoxantrone in the treatment of recurrent squamous cell carcinoma of the head and neck.
American journal of clinical oncology 1987;10(4):307-9.
1987: David J Stewart; H Hugenholtz; V DaSilva; B Benoit; M Richard; N Russell; Jean Maroun; S Verma
Cytosine arabinoside plus cisplatin and other drugs as chemotherapy for gliomas.
Seminars in oncology 1987;14(2 Suppl 1):110-5.
1987: David J Stewart; Z Grahovac; N A Russel; H Hugenholtz; S Gupta; B C Benoit; M T Richard; Jean Maroun; H S Hopkins; L Locke
Phase I study of intracarotid PCNU.
Journal of neuro-oncology 1987;5(3):245-50.
1987: David J Stewart; Jean Maroun; H Hugenholtz; B Benoit; A Girard; M Richard; N Russell; L Huebsch; J Drouin
Combined intraommaya methotrexate, cytosine arabinoside, hydrocortisone and thio-TEPA for meningeal involvement by malignancies.
Journal of neuro-oncology 1987;5(4):315-22.
1986: David J Stewart; R M Green; N Z Mikhael; V Montpetit; M Thibault; Jean Maroun
Human autopsy tissue concentrations of mitoxantrone.
Cancer treatment reports 1986;70(11):1255-61.
1986: Jean Maroun; A Maksymiuk; Elizabeth Eisenhauer; David J Stewart; V Young; Joseph L Pater
Phase II study of acivicin in non-small cell lung cancer: a National Cancer Institute of Canada Study.
Cancer treatment reports 1986;70(11):1327-8.
1986: David J Stewart; Jean Maroun; W Hirte; B Lefebvre; V Young; A F Crook; R Heringer; R McDermott
Vinblastine, adriamycin, and cyclophosphamide in the treatment of adenocarcinoma of the breast.
American journal of clinical oncology 1986;9(3):217-22.
1986: David J Stewart; Jean Maroun; G Laframboise; J Gerin-Lajoie
Cisplatin plus cytosine arabinoside in the treatment of squamous cell carcinoma of the head and neck.
American journal of clinical oncology 1986;9(3):200-3.
1986: David J Stewart; Jean Maroun; B Lefebvre; R Heringer
Neurotoxicity and efficacy of combined vinca alkaloids in breast cancer.
Cancer treatment reports 1986;70(5):571-3.
1986: David J Stewart; Jean Maroun; C Cripps; V Young; G Laframboise; J Gerin-Lajoie
Methotrexate and 5-fluorouracil in the treatment of squamous and other carcinomas of the head and neck.
Cancer chemotherapy and pharmacology 1986;17(1):91-4.
1985: David J Stewart; N Z Mikhael; A A Nanji; Rama Nair; S Kacew; K Howard; W Hirte; Jean Maroun
Renal and hepatic concentrations of platinum: relationship to cisplatin time, dose, and nephrotoxicity.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1985;3(9):1251-6.
1985: David J Stewart; Jean Maroun; B Lefebvre; R Heringer; A F Crook
Mitomycin-C plus metronidazole in advanced carcinoma of the breast.
Breast cancer research and treatment 1985;5(2):189-94.
1984: David J Stewart; Z Grahovac; B Benoit; D Addison; M T Richard; J Dennery; H Hugenholtz; N Russell; E Peterson; Jean Maroun
Intracarotid chemotherapy with a combination of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU), cis-diaminedichloroplatinum (cisplatin), and 4'-O-demethyl-1-O-(4,6-O-2-thenylidene-beta-D-glucopyranosyl) epipodophyllotoxin (VM-26) in the treatment of primary and metastatic brain tumors.
Neurosurgery 1984;15(6):828-33.
1984: Jean Maroun; A L Fields; J L Pater; David J Stewart; C Cripps; Elizabeth Eisenhauer
Phase II study of acivicin in colorectal carcinoma: a National Cancer Institute of Canada study.
Cancer treatment reports 1984;68(9):1121-3.
1984: David J Stewart; Jean Maroun; W Hirte; D Perrault; L Stolbach; C Cripps; B Lefebvre
A randomized comparison of cyclophosphamide-mitoxantrone-5-fluorouracil v cyclophosphamide-doxorubicin-5-fluorouracil in advanced breast cancer: preliminary observations.
Seminars in oncology 1984;11(3 Suppl 1):23-7.
1984: David J Stewart; N Futter; Jean Maroun; P Murphy; D McKay; P Rasuli
Intra-arterial cisplatin treatment of unresectable or medically inoperable invasive carcinoma of the bladder.
The Journal of urology 1984;131(2):258-61.
1984: David J Stewart; B Benoit; M T Richard; H Hugenholtz; J Dennery; N Russell; E Peterson; Z Grahovac; G Belanger; Jean Maroun
Treatment of malignant gliomas in adults with BCNU plus metronidazole.
Journal of neuro-oncology 1984;2(1):53-8.
1983: David J Stewart; Jean Maroun; V Young; A F Crook; H S Hopkins; R C Yan; M T Richard; H Hugenholtz; R Bélanger; R Heringer
Feasibility study of combining metronidazole with chemotherapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1983;1(1):17-23.